Liechtenstein - Healthcare Expenditure on Pharmaceuticals and Medical Non-Durable Goods by Compulsory Contributory Health Insurance Schemes and Compulsory Medical Saving Accounts (CMSA)
Since 2014, Liechtenstein Healthcare Expenditure on Pharmaceuticals and Medical Non-Durable Goods by Compulsory Contributory Health Insurance Schemes and Compulsory Medical Saving Accounts (CMSA) was up 0.9% year on year. At €522.2 Per Capita in 2019, the country was number 3 among other countries in Healthcare Expenditure on Pharmaceuticals and Medical Non-Durable Goods by Compulsory Contributory Health Insurance Schemes and Compulsory Medical Saving Accounts (CMSA). Liechtenstein is overtaken by Germany, which was number 2 with €524.79 Per Capita and is followed by Belgium with €420.62 Per Capita. Switzerland lead the ranking with €665.57 Per Capita in 2019, +3.2% compared to 2018. Switzerland recorded the best 5 years average growth at +5.4% per year, while Portugal was the worst growing country at -12.9% per year.
| Date | Euros Per Capita |
|---|---|
| 2019 | 522.20 |
| 2018 | 504.96 |
| 2017 | 538.91 |
| 2016 | 593.29 |
| 2015 | 591.06 |
How does Liechtenstein rank in Healthcare Expenditure on Pharmaceuticals and Medical Non-Durable Goods by Compulsory Contributory Health Insurance Schemes and Compulsory Medical Saving Accounts (CMSA)?
| # | 23 Countries | Euros Per Capita | Last | YoY | 5‑years CAGR | |
|---|---|---|---|---|---|---|
| 1 |
#1
Switzerland
|
665.57 | 2019 | +3.1 % | +5.3 % | View data |
| 2 |
#2
Germany
|
524.79 | 2019 | +2.3 % | +3.0 % | View data |
| 3 |
#3
Liechtenstein
|
522.20 | 2019 | +3.4 % | +0.9 % | View data |
| 4 |
#4
Belgium
|
420.62 | 2019 | +0.4 % | +3.9 % | View data |
| 5 |
#5
France
|
412.39 | 2019 | +0.6 % | +1.9 % | View data |